文献速递脊柱关节炎

鸟枪法宏基因组揭示强直性脊柱炎患者中潜在交叉反应细菌表位富集及TNFi治疗对微生物组的影响

Shotgun metagenomics reveals an enrichment of potentially cross-reactive bacterial epitopes in ankylosing spondylitis patients, as well as the effects of TNFi therapy upon microbiome composition.
PubMed 文献 · Ann Rheum Dis · 2019-10-29

该病例对照研究对250例汉族受试者的粪便行鸟枪法宏基因组测序并作SNP基因分型,再次证实强直性脊柱炎(AS)肠道菌群失调,发现TNFi治疗与紊乱微生物组向健康对照恢复相关,且AS患者粪便中富集与HLA-B27呈递表位同源的细菌肽。

要点

  • AS患者肠道菌群失调被再次证实,多种细菌物种及功能类别差异丰度。
  • TNFi治疗与AS患者紊乱微生物组向健康对照恢复相关。
  • AS患者粪便富集与HLA-B27呈递表位同源的细菌肽,TNFi后潜在致关节炎细菌肽减少。

核心结论

  • 肠道微生物组在AS发病机制中起关键作用,并提示潜在治疗和/或预防靶点。

研究设计与样本

  • 病例对照队列纳入250例汉族受试者,粪便行鸟枪法宏基因组测序,全部受试者用Illumina CoreExome SNP微阵列基因分型。

主要发现

  • 再次证实AS肠道菌群失调,多种细菌物种和功能类别差异丰度。
  • TNFi治疗与未治疗AS患者紊乱微生物组向健康对照恢复相关,包括既往与AS及其他相关疾病相关的多种重要细菌物种。
  • AS患者粪便中富集与HLA-B27呈递表位同源的细菌肽,提示HLA-B27未能清除这些肽或它们参与驱动HLA-B27相关免疫反应。
  • 相对未治疗患者,AS患者TNFi治疗与潜在致关节炎细菌肽减少相关。

临床怎么用

  • 关注AS患者肠道菌群失调,TNFi治疗可能部分恢复微生物组并减少潜在致关节炎细菌肽。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Diverse evidence including clinical, genetic and microbiome studies support a major role of the gut microbiome in the common immune-mediated arthropathy, ankylosing spondylitis (AS). We set out to (1) further define the key microbial characteristics driving disease, and (2) examine the effects of tumour necrosis factor-inhibitor (TNFi) therapy upon the microbiome. METHODS: The stools from a case-control cohort of 250 Han-Chinese subjects underwent shotgun metagenomic sequencing. All subjects were genotyped using the Illumina CoreExome SNP microarray. RESULTS: Previous reports of gut dysbiosis in AS were reconfirmed and several notable bacterial species and functional categories were differentially abundant. TNFi therapy was correlated with a restoration the perturbed microbiome observed in untreated AS cases to that of healthy controls, including several important bacterial species that have been previously associated with AS and other related diseases. Enrichment of bacterial peptides homologous to HLA-B27-presented epitopes was observed in the stools of patients with AS, suggesting that either HLA-B27 fails to clear these or that they are involved in driving HLA-B27-associated immune reactions. TNFi therapy largely restored the perturbed microbiome observed in untreated AS cases to that of healthy controls, including several important bacterial species that have been previously associated with AS and other related diseases. TNFi therapy of patients with AS was also associated with a reduction of potentially arthritogenic bacterial peptides, relative to untreated patients. CONCLUSION: These findings emphasise the key role that the gut microbiome plays in driving the pathogenesis of AS and highlight potential therapeutic and/or preventative targets.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Yin J, Sternes PR, Wang M, et al. Shotgun metagenomics reveals an enrichment of potentially cross-reactive bacterial epitopes in ankylosing spondylitis patients, as well as the effects of TNFi therapy upon microbiome composition. Ann Rheum Dis. 2019. PMID: 31662318. doi:10.1136/annrheumdis-2019-215763

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。